Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
1h
Intellia Therapeutics: Promising Phase 2 Results and Attractive Valuation Spur Buy Recommendation
JonesTrading analyst Debanjana Chatterjee has reiterated their bullish stance on NTLA stock, giving a Buy rating on October 16. Debanjana ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Workers reject new contract
Accused of plagiarism
Oldest person in US dies
'Tarzan' star Ron Ely dies
Courthouse attack charges
Court orders new sentence
Grizzly bear fatally struck
DOJ warns Musk's PAC?
Reporter struck by shrapnel
Kristy now Category 4
Weekly jobless claims fall
Sued by ‘ring boys’
LA Times editor quits
Pneumococcal vax advice
Carbon removal firms report
New lead dust standards
To join Harris at rally
Seeks WI ballot exit
911 calls from rally released
Georgia repels cyberattack
Israeli strike on school
Wins EU antitrust case
Unveils new AI rules
PA provisional ballot ruling
Hikes annual pass prices
US charges media tycoon
Georgia citizenship audit
$135 million in Gaza aid
Data privacy violations fine
Feedback